Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.conduitpharma.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

Trick2MoneyisHavingSum Feb. 3 at 2:21 PM

$CDT 👀 the sideways consolidation? Now form the 'W' pattern

0 · Reply

killer_7 Feb. 3 at 2:17 PM

$CDT yolo

0 · Reply

Trick2MoneyisHavingSum Feb. 3 at 2:03 PM

$CDT aren't all stocks pos until they aren't?

0 · Reply

max315 Feb. 3 at 2:02 PM

$CDT a lot of new people in here that will soon fade away like this pos stock.

0 · Reply

Trick2MoneyisHavingSum Feb. 3 at 2:01 PM

$CDT why would the warrant holders want to sell at $1.35 when they can sell at $2+?

1 · Reply

max315 Feb. 3 at 2:00 PM

$CDT Another offering? well shit. not touching again.

1 · Reply

max315 Feb. 3 at 1:33 PM

$CDT Could easily go under 1 now that those guys are repaid, and set up for the next r/s.

0 · Reply

max315 Feb. 3 at 1:32 PM

$CDT 1.35 is where the bonds/warrants are. That was the meaning of the 'pump' guys. It's dead now. But nice play for @Nevilhch and @CW630 who got in under 1.10 yesterday.

1 · Reply

PiviotPointMooncake Feb. 3 at 1:31 PM

$CDT a lot of bid sitting gotta slap

0 · Reply

Louisjadot Feb. 3 at 1:28 PM

$CDT a lot of 1.18 bids

0 · Reply

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Oct 17, 2025, 8:30 AM EDT - 3 months ago

CDT Equity Increases Bitcoin Holding

Oct 9, 2025, 8:00 AM EDT - 4 months ago

CDT Equity Inc. Announces Reverse Stock Split

Sep 17, 2025, 8:30 AM EDT - 4 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 5 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 6 months ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 7 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 7 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 11 months ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AZN

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Mar 19, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 11, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Sep 22, 2023, 9:01 AM EDT - 2 years ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

Trick2MoneyisHavingSum Feb. 3 at 2:21 PM

$CDT 👀 the sideways consolidation? Now form the 'W' pattern

0 · Reply

killer_7 Feb. 3 at 2:17 PM

$CDT yolo

0 · Reply

Trick2MoneyisHavingSum Feb. 3 at 2:03 PM

$CDT aren't all stocks pos until they aren't?

0 · Reply

max315 Feb. 3 at 2:02 PM

$CDT a lot of new people in here that will soon fade away like this pos stock.

0 · Reply

Trick2MoneyisHavingSum Feb. 3 at 2:01 PM

$CDT why would the warrant holders want to sell at $1.35 when they can sell at $2+?

1 · Reply

max315 Feb. 3 at 2:00 PM

$CDT Another offering? well shit. not touching again.

1 · Reply

max315 Feb. 3 at 1:33 PM

$CDT Could easily go under 1 now that those guys are repaid, and set up for the next r/s.

0 · Reply

max315 Feb. 3 at 1:32 PM

$CDT 1.35 is where the bonds/warrants are. That was the meaning of the 'pump' guys. It's dead now. But nice play for @Nevilhch and @CW630 who got in under 1.10 yesterday.

1 · Reply

PiviotPointMooncake Feb. 3 at 1:31 PM

$CDT a lot of bid sitting gotta slap

0 · Reply

Louisjadot Feb. 3 at 1:28 PM

$CDT a lot of 1.18 bids

0 · Reply

Trick2MoneyisHavingSum Feb. 3 at 1:23 PM

$CDT you guys pushed it over $1.60 twice this morning lfg PEOPLE

0 · Reply

Trick2MoneyisHavingSum Feb. 3 at 1:21 PM

$CDT what's lvl 2 👀 like?